Indian Journal Of Clinical Biochemistry由Springer Nature出版商出版,收稿方向涵盖BIOCHEMISTRY & MOLECULAR BIOLOGY全领域,平均审稿速度 ,影响因子指数1.5,该期刊近期没有被列入国际期刊预警名单,广大学者值得一试。WOS分区(数据版本:2023-2024年最新版) 按JIF指标学科分区 收录子集 分区 排名 百分位 学科:BIOCHEMISTRY ...
《Indian Journal Of Clinical Biochemistry》国际简称:INDIAN J CLIN BIOCHE,是由出版商Springer Nature出版的一本致力于发布--研究新成果的的专业学术期刊。主要发表刊登有创见的学术论文文章、行业最新科研成果,扼要报道阶段性研究成果和重要研究工作的最新进展,选载
《印度临床生物化学杂志》(Indian Journal Of Clinical Biochemistry)是一本以BIOCHEMISTRY & MOLECULAR BIOLOGY综合研究为特色的国际期刊。该刊由Springer Nature出版商刊期4 issues per year。该刊已被国际重要权威数据库SCIE收录。期刊聚焦BIOCHEMISTRY & MOLECULAR BIOLOGY领域的重点研究和前沿进展,及时刊载和报道该领域的...
Indian Journal of Clinical Biochemistry, 2003, 18 (2) 161-168 SECONDARY IMMUNIZATION INHIBITS DRUG INDUCED APOPTOSIS IN VIVO 来自 medind.nic.in 喜欢 0 阅读量: 36 作者:WC Pereira,MS Rao,DM Vasudevan 摘要: Immunization with a proper dose of an antigenic stimulus leads to cell proliferation and...
The primary mission of the Indian Journal of Clinical Biochemistry is to serve the public interest in health care by providing leadership in clinical laboratory science to national professional societies, the diagnostics industry, government and non-government organizations. The journal also acts as an ...
The primary mission of the Indian Journal of Clinical Biochemistry is to serve the public interest in health care by providing leadership in clinical ...
期刊全称 Indian Journal of Clinical Biochemistry 期刊简称 Print ISSN 0970-1915 Online ISSN 0974-0422 期刊出版社 是否开放获取 Open Access,OA 暂无数据 官网地址 期刊所属领域 期刊简介 JCR分区索引信息2021年数据 是否是SCIE(SCI) 注:SCI已经完全被SCIE取代,参考:SCI被取代 ...
期刊名称:《Journal of Parasitic Diseases: Official Organ of the Indian Society for Parasitology》 | 2016年第3期 关键词: Toxoplasma gondii Sero-epidemiology Congenital Risk factors African Arab; 2.Comparison of microscopic and immunoassay examination in the diagnosis of intestinal protozoa of humans ...
The renal Fanconi syndrome which results from renal tubular dysfunction can be either associated with various inbom errors of metabolism or acquired from v
detection of ACS was 78.0% and 82.7% compared to 58.0% and 60.0%, respectively for the CK-MB assay. The area under the ROC curve of IMA for ischemic v/s non-ischemic patients was 0.834. IMA appears to be developing into a new and very potent marker, of cardiac ischemia....